Patents by Inventor Ronald Keith Wolff

Ronald Keith Wolff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7112341
    Abstract: Provided are stabilized follicle stimulating protein (FSP) dry powder compositions for aerosolized delivery to the deep lung, methods of preparing and administering such compositions, and methods for treating infertility involving administering the dry powders by pulmonary delivery to the deep lung.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: September 26, 2006
    Assignee: Nektar Therapeutics
    Inventors: Sudha Nagarajan, John S. Patton, David B. Bennett, Joanne Greene, Hi-Shi Chiang, Cheryl L. M. Stults, Geraldine Venthoye, Darrel LaVern Allen, Benjamin Lee Hughes, Mary Stiff-Torvik, Ronald Keith Wolff, William David Roeder
  • Publication number: 20040214747
    Abstract: The claimed invention relates to a method of administering AspB28-human insulin by inhalation, a method for treating diabetes by administering AspB28-human insulin by inhalation, and a method for treating hyperglycemia by administering AspB28-human insulin by inhalation.
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Inventors: Richard Dennis DiMarchi, Roger Garrick Harrison, Ronald Keith Wolff
  • Publication number: 20040120897
    Abstract: The claimed invention relates to a method of administering glucagon-like peptide-1 molecules by inhalation, a method for treating diabetes by administering glucagon-like peptide-1 molecules by inhalation, and a method for treating hyperglycemia by administering glucagon-like peptide-1 molecules by inhalation.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 24, 2004
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Patent number: 6720407
    Abstract: The claimed invention relates to a method of administering glucagon-like peptide-1 molecules by inhalation, a method for treating diabetes by administering glucagon-like peptide-1 molecules by inhalation, and a method for treating hyperglycemia by administering glucagon-like peptide-1 molecules by inhalation.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: April 13, 2004
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Patent number: 6335316
    Abstract: The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: January 1, 2002
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Publication number: 20010053761
    Abstract: The claimed invention relates to a method of administering AspB28-human insulin by inhalation, a method for treating diabetes by administering AspB28-human insulin by inhalation, and a method for treating hyperglycemia by administering AspB28-human insulin by inhalation.
    Type: Application
    Filed: January 6, 1999
    Publication date: December 20, 2001
    Inventors: RICHARD DENNIS DIMARCHI, ROGER GARRICK HARRISON, RONALD KEITH WOLFF
  • Publication number: 20010007853
    Abstract: The claimed invention relates to a method of administering an insulin analog by inhalation, a method for treating diabetes by administering an insulin analog by inhalation, and a method for treating hyperglycemia by administering an insulin analog by inhalation.
    Type: Application
    Filed: January 6, 1999
    Publication date: July 12, 2001
    Inventors: RICHARD DENNIS DIMARCHI, ROGER GARRICK HARRISON, RONALD KEITH WOLFF
  • Patent number: 6080762
    Abstract: The present invention relates to formulations and methods for pulmonary and nasal administration of raloxifene.
    Type: Grant
    Filed: April 8, 1999
    Date of Patent: June 27, 2000
    Assignee: Eli Lilly and Company
    Inventors: Darrel LaVern Allen, Ronald Keith Wolff, Paula Ann Leiter, Richard Leon Tielking
  • Patent number: 6051551
    Abstract: The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: April 18, 2000
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff